01 1Chattem Chemicals, Inc.
02 1SpecGx LLC
01 1Dihydrocodeine Bitartrate
02 1dihydrocodeine bitartrate
01 1Ireland
02 1U.S.A
NDC Package Code : 61960-0100
Start Marketing Date : 2018-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-1578
Start Marketing Date : 2013-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Dihydrocodeine Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydrocodeine Tartrate, including repackagers and relabelers. The FDA regulates Dihydrocodeine Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydrocodeine Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydrocodeine Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydrocodeine Tartrate supplier is an individual or a company that provides Dihydrocodeine Tartrate active pharmaceutical ingredient (API) or Dihydrocodeine Tartrate finished formulations upon request. The Dihydrocodeine Tartrate suppliers may include Dihydrocodeine Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydrocodeine Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dihydrocodeine Tartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dihydrocodeine Tartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dihydrocodeine Tartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dihydrocodeine Tartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dihydrocodeine Tartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dihydrocodeine Tartrate suppliers with NDC on PharmaCompass.
We have 2 companies offering Dihydrocodeine Tartrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
